Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://med.cuhk.edu.hk/press-releases/cuhk-world-first-shows-ai-derived-mri-brain-indices-aid-clinical-detection-of-three-cognitive-disorders-at-early-stage
https://med.cuhk.edu.hk/press-releases/cuhk-world-first-shows-ai-derived-mri-brain-indices-aid-clinical-detection-of-three-cognitive-disorders-at-early-stage

CUHK World First Shows AI-derived MRI Brain Indices Aid Clinical Detection of Three Cognitive Disorders at Early Stage

A series of researches recently done by CU Medicine has validated the use of AI-derived MRI brain indices for the detection of early-stage cognitive disorders.

A series of researches recently done by CU Medicine has validated the use of AI-derived MRI brain indices for the detection of early-stage cognitive disorders, including Alzheimer’s disease (AD), Lewy Bodies and frontotemporal dementia. (From left) Professor Winnie C.W. CHU, Director of the Gerald Choa Neuroscience Centre MRI Core Facility and Professor of the Department of Imaging and Interventional Radiology; Professor Vincent C.T. MOK, Director of the Therese Pei Fong Chow Research Centre for Prevention of Dementia and Head (Academic Affairs) of the Division of Neurology, Department of Medicine and Therapeutics; and Dr. Lisa W.C. AU, Clinical Professional Consultant of Division of Neurology, Department of Medicine and Therapeutics, CU Medicine.

To differentiate early Alzheimer’s disease (AD) from normal ageing and to differentiate AD from other common neurodegenerative cognitive disorders such as dementia with Lewy Bodies (DLB), and frontotemporal dementia (FTD) at early stage is challenging. Clinical features of these disorders frequently overlap especially at the early stage of the disease.

 

A series of researches recently done by the Faculty of Medicine at The Chinese University of Hong Kong (CU Medicine) has validated the use of artificial intelligence derived (AI-derived) MRI indices for the detection of early-stage cognitive disorders, including AD, DLB and FTD. The research team is the first in the world to prove such indices can achieve high accuracy for the detection of these three types of early-stage neurodegenerative cognitive disorders in clinical setting.    

 

Early detection is the key to effective treatment for dementia

 

Dementia affects one in every ten older adults in Hong Kong and is a major threat to the quality of life of patients and their families. With the rapidly ageing population in Hong Kong, the number of older people suffering from dementia is estimated to rise dramatically from about 100,000 in 2009 to over 330,000 in 2039. Early detection and intervention provide the greatest opportunity to reduce the disease burden. Yet to date, a simple and effective biomarker that aids early detection is still lacking.

 

Pathological brain changes of common neurodegenerative cognitive disorders often include accumulation of certain abnormal proteins (e.g. amyloid plaques) or loss of certain neurotransmitters (e.g. dopamine). Although current positron emission tomography (PET) or cerebral spinal fluid (CSF) examinations are able to detect these biological changes, these tests are still not widely accessible.

 

Prof. Vincent Mok
 
Professor Vincent C.T. MOK, Director of the Therese Pei Fong Chow Research Centre for Prevention of Dementia and Head (Academic Affairs) of the Division of Neurology, Department of Medicine and Therapeutics at CU Medicine said, “With the advent of treatments like anti-amyloid therapy, multi-domain life-style based intervention, and nutritional therapy, the progression of AD can be potentially slowed down when detected at an early stage. Thus, a more convenient and precise screening method for detection of early AD will be very important.”

 

Prof. Winnie Chu
 
Apart from the above-mentioned brain changes in abnormal proteins or neurotransmitters, the brain also undergoes atrophy, which involves different brain regions for the respective cognitive disorders. Professor Winnie C.W. CHU, Director of the Gerald Choa Neuroscience Centre MRI Core Facility and Professor of the Department of Imaging and Interventional Radiology at CU Medicine commented, “This pattern of brain atrophy may usually be detected by visual inspection on MRI when the disease has already reached an advanced stage. However, it is very difficult to detect the presence and pattern of brain atrophy at the early stage when there is only mild cognitive impairment.”

 

AI-derived MRI biomarkers can detect early AD and other common neurodegenerative cognitive disorders

With the development of AI that can enable “pattern recognition” and MRI automatic computerised volumetric method that can quantify subtle changes in volume of multiple brain regions, the Division of Neurology and the Department of Imaging and Interventional Radiology at CU Medicine  utilised technologies which incorporate AI and MRI automatic post-processing methods to investigate the ability of AI-derived MRI biomarkers in detecting early AD and other common neurodegenerative cognitive disorders.

 

Since 2019, the teams investigated a total of 2,121 MRIs of older adults, with 635 AD patients, 61 DLB patients, 97 FTD patients, and 1,328 elderlies with normal cognition. The studies showed that certain AI-derived MRI Indices could increase the sensitivity in the detection of mild AD by 25% compared to visual inspection.

 

 

Sensitivity

Specificity

Visual Inspection of mild AD

67%

81%

AI-derived MRI Index for the detection of mild AD

92%

81%

The AI-derived MRI Indices could also achieve a good performance in detecting FTD of mild to moderate stage (96%) and in the detection of mild DLB (83%). Subjects who were tested positive could then receive further investigations via PET or CSF to confirm the diagnosis.

 

 

Sensitivity

Specificity

AI-derived MRI Index for the detection of FTD (mild to moderate stage)

96%

70%

AI-derived MRI Index for the detection of mild DLB

83%

86%

The required MRI scanning time can be as short as 15 minutes and the AI-derived MRI indices can be generated automatically in 10 minutes once the images are uploaded to the software, which can be operated via a cloud platform. In addition, other volumetric information of separate brain regions as well as the volume of cerebral small vessel disease-related brain lesion (e.g. white matter lesion) can also be generated, which provides additional information with respect to other brain changes that could impair cognition.

 

Dr. Lisa Au
 
“In the past, MRI has been used commonly in clinical practice mainly to rule out other non-degenerative cognitive disorders, such as cerebral small vessel disease, hydrocephalus, or brain tumor. With the rapid development and incorporation of AI technology in MRI scanning, we believed that MRI will further aid the detection of AD and other common neurodegenerative cognitive disorders at an earlier stage.” said Dr. Lisa W.C. AU, Clinical Professional Consultant of Division of Neurology, Department of Medicine and Therapeutics, CU Medicine.

 

Patient Mr. Ho
 
Mr. HO appeared to have poor memory around 10 years ago, his family wasn’t attentive until they found him with emotional problems. He received the first MRI test in 2016 but detected no abnormality. A year later, he was found to have high risk of AD via the AI-derived MRI brain index and was later diagnosed with the disease.

More Press Releases

CUHK Sets up the Global First Research Registry on Early Onset Dementia in Chinese Population

CUHK Sets up the Global First Research Registry on Early Onset Dementia in Chinese Population

Research
CUHK Screening Reveals 1 in 3 Older Adults in Community Suffer Brain Small Vessel Disease, Early Prevention Recommended

CUHK Screening Reveals 1 in 3 Older Adults in Community Suffer Brain Small Vessel Disease, Early Prevention Recommended

Clinical service
CU Medicine completes world’s first study evaluating intracerebral hemorrhage treatments for Chinese patients with atrial fibrillation

CU Medicine completes world’s first study evaluating intracerebral hemorrhage treatments for Chinese patients with atrial fibrillation

Research
CU Medicine study reveals increasing cognitive activity participation strengthens brain network

CU Medicine study reveals increasing cognitive activity participation strengthens brain network

Research
CUHK Research Team Develops an AI System for Detecting COVID-19 Infections in CT with a Privacy Preserving Multinational Validation Study

CUHK Research Team Develops an AI System for Detecting COVID-19 Infections in CT with a Privacy Preserving Multinational Validation Study

Research
Most Deaths from COVID-19 in Hong Kong are of 60 Years Old or Above CUHK Initiated International Effort in Devising Strategies to Protect Older People with Dementia amid COVID-19 Pandemic

Most Deaths from COVID-19 in Hong Kong are of 60 Years Old or Above CUHK Initiated International Effort in Devising Strategies to Protect Older People with Dementia amid COVID-19 Pandemic

Research
Joint Study by CUHK and HKSH Reveals Patients with Comorbid REM Sleep Behavior Disorder and Depression may Suffer from Early-stage Neurodegeneration

Joint Study by CUHK and HKSH Reveals Patients with Comorbid REM Sleep Behavior Disorder and Depression may Suffer from Early-stage Neurodegeneration

Research
CUHK Research Reveals that Stroke Triggers Alzheimer’s Dementia Risk of Alzheimer’s Dementia Can be Reduced by Enhancing Vascular Health

CUHK Research Reveals that Stroke Triggers Alzheimer’s Dementia Risk of Alzheimer’s Dementia Can be Reduced by Enhancing Vascular Health

Research
CU Medicine receives the Li Ka Shing Foundation’s donation of Asia’s first Histotripsy 2.0 system 30 patients sponsored to receive novel treatment for liver tumours

CU Medicine receives the Li Ka Shing Foundation’s donation of Asia’s first Histotripsy 2.0 system 30 patients sponsored to receive novel treatment for liver tumours

Donation
CUHK’s collaborative studies with institutes in Southeast Asia and the UK offer new insights into the roles of large language models in public health research

CUHK’s collaborative studies with institutes in Southeast Asia and the UK offer new insights into the roles of large language models in public health research

Research
CU Medicine pioneers the introduction of a novel AI system for detection of early gastric cancers during upper GI endoscopy to increase the detection rate of the disease and facilitate endoscopists’ training

CU Medicine pioneers the introduction of a novel AI system for detection of early gastric cancers during upper GI endoscopy to increase the detection rate of the disease and facilitate endoscopists’ training

International collaboration
CUHK’s Automatic Retinal Image Analysis effective to detect autism and depression Clinch top awards at the International Exhibition of Inventions Geneva

CUHK’s Automatic Retinal Image Analysis effective to detect autism and depression Clinch top awards at the International Exhibition of Inventions Geneva

Awards and honors
CU Medicine-developed app proves effective in assessing depression

CU Medicine-developed app proves effective in assessing depression

Research
CU Medicine finds from free-text narratives that COVID-19 symptoms change with virus mutations and vaccination status, and demonstrates AI large language models contribute to infectious disease research

CU Medicine finds from free-text narratives that COVID-19 symptoms change with virus mutations and vaccination status, and demonstrates AI large language models contribute to infectious disease research

Research
CU Medicine proves AI-assisted colonoscopy increases adenoma detection rate by 40%, and  trains a new AI platform to assist early-stage gastrointestinal cancer treatment

CU Medicine proves AI-assisted colonoscopy increases adenoma detection rate by 40%, and trains a new AI platform to assist early-stage gastrointestinal cancer treatment

Surgical advancement
CUHK develops an interventional catheterisation-integrated swarming microrobotic platform for aneurysm embolisation treatment: a new non-invasive approach

CUHK develops an interventional catheterisation-integrated swarming microrobotic platform for aneurysm embolisation treatment: a new non-invasive approach

Research
CUHK develops an efficient approach to estimate the risk of heart disease in people living with HIV

CUHK develops an efficient approach to estimate the risk of heart disease in people living with HIV

Research
CUHK leading Asia’s battle to improve bile duct cancer survival rates by developing a novel combinational strategy in clinical trial

CUHK leading Asia’s battle to improve bile duct cancer survival rates by developing a novel combinational strategy in clinical trial

Research
CUHK celebrates World Brain Day 2022  Calls for prevention of cerebral small vessel disease to lower the risks of stroke and cognitive impairment

CUHK celebrates World Brain Day 2022 Calls for prevention of cerebral small vessel disease to lower the risks of stroke and cognitive impairment

Research
CUHK Identifies Outcome Indicators for Benign Prostatic Hyperplasia Patients Receiving Prostatic Artery Embolisation

CUHK Identifies Outcome Indicators for Benign Prostatic Hyperplasia Patients Receiving Prostatic Artery Embolisation

Research
CUHK Proves Modified HIFU Treatment Effective for Treating Uterine Fibroids

CUHK Proves Modified HIFU Treatment Effective for Treating Uterine Fibroids

Research
CUHK Establishes Margaret K.L. Cheung Research Centre for Management of Parkinsonism  To Develop Innovative Solutions to Slow Disease Progression

CUHK Establishes Margaret K.L. Cheung Research Centre for Management of Parkinsonism To Develop Innovative Solutions to Slow Disease Progression

Research
CUHK Conducts World’s First Family Study on Rapid Eye Movement Sleep Behaviour Disorder to Investigate Familial Link with Parkinson’s Disease

CUHK Conducts World’s First Family Study on Rapid Eye Movement Sleep Behaviour Disorder to Investigate Familial Link with Parkinson’s Disease

Research
CUHK Pioneers in Developing Standardised Tests for Screening Cognitive Impairment in the Ageing Population in Hong Kong

CUHK Pioneers in Developing Standardised Tests for Screening Cognitive Impairment in the Ageing Population in Hong Kong

Clinical service
CUHK Study Proves Ablative Chemoembolization Doubles the Progression-Free Survival for Liver Cancer Patients

CUHK Study Proves Ablative Chemoembolization Doubles the Progression-Free Survival for Liver Cancer Patients

Research
CUHK Launches World’s First Study Utilizing Retinal Imaging for Alzheimer’s Disease Screening in Chinese Population

CUHK Launches World’s First Study Utilizing Retinal Imaging for Alzheimer’s Disease Screening in Chinese Population

Research
CUHK’s Gerald Choa Neuroscience Centre Unveils Mystery of How Brain Learns Motor Skills

CUHK’s Gerald Choa Neuroscience Centre Unveils Mystery of How Brain Learns Motor Skills

Research
CUHK Proves Prostate Artery Embolization Effective for Benign Prostatic Hyperplasia

CUHK Proves Prostate Artery Embolization Effective for Benign Prostatic Hyperplasia

Research
CUHK Opens Therese Pei Fong Chow Research Centre for Prevention of Dementia and Establishes a One-stop Online Platform to Provide Information on Dementia

CUHK Opens Therese Pei Fong Chow Research Centre for Prevention of Dementia and Establishes a One-stop Online Platform to Provide Information on Dementia

Research
CUHK’s New Prostatic Artery Embolization Shows 90% Success Rate in Relieving Symptoms of Benign Prostatic Hyperplasia

CUHK’s New Prostatic Artery Embolization Shows 90% Success Rate in Relieving Symptoms of Benign Prostatic Hyperplasia

Clinical service
CUHK and PWH Introduce Leading 3D Imaging System which Reduces Radiation Dosage by 90%

CUHK and PWH Introduce Leading 3D Imaging System which Reduces Radiation Dosage by 90%

Clinical service
CUHK Reveals Effectiveness of TEA for Treating Liver Cancer with a 70% Chance of Completely Destroying Tumor

CUHK Reveals Effectiveness of TEA for Treating Liver Cancer with a 70% Chance of Completely Destroying Tumor

Research
Radiotherapy to Head and Neck Raises Risk for Stroke CUHK Proved Effectiveness of Carotid Angioplasty and Stenting

Radiotherapy to Head and Neck Raises Risk for Stroke CUHK Proved Effectiveness of Carotid Angioplasty and Stenting

Research
CUHK Succeeded in Animal Study and Clinical Case of Percutaneous Nanoknife New Breakthrough in Cancer Treatment

CUHK Succeeded in Animal Study and Clinical Case of Percutaneous Nanoknife New Breakthrough in Cancer Treatment

Research
CUHK Develops an Automatic Retinal Image Analysis System to Help Diabetes Patients and Elderly Prevent Stroke

CUHK Develops an Automatic Retinal Image Analysis System to Help Diabetes Patients and Elderly Prevent Stroke

Research
CUHK Proves a Non-invasive Technology Can Successfully Cure Cerebral Arteriovenous Malformation

CUHK Proves a Non-invasive Technology Can Successfully Cure Cerebral Arteriovenous Malformation

Clinical service
Good News for Asian Patients First Local Clinical Study Shows High Success Rate and Effectiveness of Stenting for Intracranial Stenosis in Preventing Ischaemic Stroke

Good News for Asian Patients First Local Clinical Study Shows High Success Rate and Effectiveness of Stenting for Intracranial Stenosis in Preventing Ischaemic Stroke

Research
CUHK Pioneers MRI Iron Assessment for Thalassemia Children in Southern China

CUHK Pioneers MRI Iron Assessment for Thalassemia Children in Southern China

Clinical service
CUHK Proves the Potent Efficacy of Stenting for Carotid Artery Narrowing and Cardiac Contractility Modulation for Heart Failure

CUHK Proves the Potent Efficacy of Stenting for Carotid Artery Narrowing and Cardiac Contractility Modulation for Heart Failure

Research

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.